An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females

NCT01403038 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Folliculogenesis

Interventions

DRUG: Elagolix
DRUG: Elagolix
DRUG: Elagolix
DRUG: Elagolix
DRUG: Elagolix
DRUG: Elagolix
DRUG: elagolix

Sponsor

AbbVie (prior sponsor, Abbott)

Collaborators

[object Object]